Great to host @AdamSharpMedOnc to discuss novel treatments for mCRPC. We had an interesting discussion and gained thorough insights into combination treatment approaches. Looking forward to refreshing novel ideas at ASCO 2026!
There are a number of studies that suggest the RAF-MEK-ERK-RSK cascade, a major #Oncogenic pathway, is activated in #ProstateCancer and this increases as the disease progresses. ๐ฅผ
Dr. @AdamSharpMedOnc and @ICR_London collaborators discuss. ๐ฃ๏ธ
๐ https://t.co/0iPbZbNo9O
Sometimes good is good and bad is bad; showing this time and time again may at best be incremental; feel we need to be pushing more discovery (personal bias always acknowledged - just feel we are doing less and less).
Brilliant day with @AdamSharpMedOnc and his team of #prostatecancer researchers at The Institute of Cancer Research. Always a privilege to be invited and leave full of hope. A very special group of researchers
Brilliant day with @AdamSharpMedOnc and his team of #prostatecancer researchers at The Institute of Cancer Research. Always a privilege to be invited and leave full of hope. A very special group of researchers
Ever wonder how toggling protein synthesis impacts cellular identity? Dr. Rashmi Mishra @HsiehLab did and through a clever drug screen discovered that the cap-binding domain of eIF4E regulates lineage fate in prostate cancer. Story hit newsstands today: https://t.co/dwv6z2untc